Morning Market Gainers

shares climbed 74.06 percent to $89.99 after the company agreed to be acquired for $13.9 billion.

shares surged 24.39 percent to $7.65 after the company reported "going private" transaction for $8.85 per share.

shares rose 22.73 percent to $1.89 after the company reported positive results from Phase II study of Pracinostat in acute myeloid leukemia.

shares jumped 18.39 percent to $10.19 after the company reported positive results in its European Phase III study for its breakthrough therapy for colorectal cancer.

surged 10.80 percent to $4.82 after the company reported the NDA resubmission of its Epinephrine Pre-Filled Syringe application to the FDA.

shares rose 10.66 percent to $15.52 on

go-private deal for $92 per share.

shares jumped 2.77 percent to $22.30 after the company reported BPX-501 clinical data.